🟢 Opus Genetics is trading 7.45% up in pre-market — no clear catalyst identified

Opus Genetics is trading 7.45% up at $4.04, with no clear company-specific catalyst identified for August 13, 2026.

• The latest confirmed corporate update was its August 6 second-quarter report.
• September OPGx-BEST1 data remains a future milestone, not a new overnight announcement.
• Broader markets are nearly flat, so the move cannot be confidently attributed to macro sentiment.